All News

August 5, 2009 5:21 AM CT At the 2009 convention of the American Association for Thoracic Surgery, StopAfib.org had the opportunity to sit down and talk with Dr. Michael Argenziano, Director of the Surgical Arrhythmia Program at NY-Presbyterian/Columbia University Medical Center. One interesting bit of trivia about Dr. Argenziano is that you may recognize the …

August 3, 2009 5:34 AM CT I recently spoke at a conference at which Dr. Anne Cahill, a cardiothoracic surgeon, followed me and was talking about women's heart health. She mentioned some findings regarding supplements and heart health, including the impact of Omega-3 fatty acids on arrhythmias. Afterwards, we had an opportunity to capture some …

July 30, 2009 5:43 AM CT Contact: Mellanie True Hills at www.StopAfib.org or 940-466-9898 Dallas, TX—On behalf of the atrial fibrillation patient community, StopAfib.org applauds the U.S. Food and Drug Administration (FDA) for approving Multaq® (dronedarone) and providing a safer option for those with atrial fibrillation (AF) and atrial flutter (AFL). Amiodarone is considered the …

July 22, 2009 5:21 AM CT September is currently designated as Atrial Fibrillation Month in Chase's Calendar of Events, the international event register. On July 22, a resolution was introduced into the U.S. Senate that would officially designate September in the U.S. as “National Atrial Fibrillation Awareness Month.” Senators Russell Feingold (D-WI), Susan Collins (R-ME), …

July 16, 2009 5:54 AM CT Two separate studies have independently identified new variants in the ZFHX3 gene that are associated with an increased risk of atrial fibrillation and stroke. This is the second gene to be identified with increased risk of atrial fibrillation and stroke. At least one third of those of European descent …

July 7, 2009 6:20 AM CT In this video, Dr. David Wilber, George M. Eisenberg Professor of Medicine and Director, Cardiovascular Institute and Division of Cardiology at Loyola University Medical Center, talks about atrial fibrillation findings reported on at the Heart Rhythm Society's 2009 annual meeting in Boston. He talks about the results of a large multicenter …

We had the opportunity to talk with Dr. Steven Hao at the Heart Rhythm Society 2009 annual meeting. Dr. Hao is Director of Electrophysiology for Northern California Heart Care and Director of the Electrophysiology Labs at California Pacific Medical Center and Marin General Hospital. In this interview, Dr. Steven Hao talks about the presentation at …

July 2, 2009 5:21 AM CT FDA approval of Multaq® (dronedarone), which has been highly anticipated in the afib community, was just announced. Below is the official press release. FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter - Multaq® approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or …

July 1, 2009 6:21 AM CT The American Recovery and Reinvestment Act of 2009 allocated $1.1 billion for research into the comparative effectiveness of different medical treatments and launched projects to identify and prioritize comparative effectiveness research (CER). Treatment of atrial fibrillation was just named as a high priority item on this agenda. Comparative effectiveness …